$196 Billion is the total value of MWG Management Ltd.'s 3 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BEAM | BEAM THERAPEUTICS INC | $91,788,589 | +81994.8% | 2,346,934 | 0.0% | 46.86% | +8.8% | |
| LYEL | LYELL IMMUNOPHARMA INC | $69,963,292 | +47239.7% | 20,162,332 | 0.0% | 35.72% | -37.3% | |
| New | PRIME MEDICINE INC | $34,110,576 | – | 1,835,876 | +100.0% | 17.42% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Milky Way Investments Group Ltd. #1
Signatures
The EDGAR filing(s) were signed by:
- Nicholas Lane — Director
- MWG Management Ltd. holdings (13F-HR)
- MWG Management Ltd. ownership history
- MWG Management Ltd. portfolio value
- MWG Management Ltd. filings
- Similar filers BETA
Compare quarterly holdings
Export MWG Management Ltd.'s holdings